BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

806 related articles for article (PubMed ID: 28869458)

  • 1. Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke.
    Beye A; Pindur G
    Clin Hemorheol Microcirc; 2017; 67(3-4):261-266. PubMed ID: 28869458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined heterozygosity of factor V leiden and the G20210A prothrombin gene mutation in a patient with cerebral cortical vein thrombosis.
    Liu XY; Gabig TG; Bang NU
    Am J Hematol; 2000 Jul; 64(3):226-8. PubMed ID: 10861823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years.
    Lalouschek W; Schillinger M; Hsieh K; Endler G; Tentschert S; Lang W; Cheng S; Mannhalter C
    Stroke; 2005 Jul; 36(7):1405-9. PubMed ID: 15947254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower contribution of factor V Leiden or G202104 mutations to ischemic stroke in patients with clinical risk factors: pair-matched case-control study.
    Eterović D; Titlić M; Culić V; Zadro R; Primorac D
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):188-93. PubMed ID: 17456629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factor V Leiden and prothrombin G20210A among Chilean patients with venous and arterial thrombosis].
    Palomo I; Pereira J; Alarcón M; Pinochet C; Vélez MT; Hidalgo P; Skagerberg K; Poblete F
    Rev Med Chil; 2005 Dec; 133(12):1425-33. PubMed ID: 16446869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults.
    Voetsch B; Damasceno BP; Camargo EC; Massaro A; Bacheschi LA; Scaff M; Annichino-Bizzacchi JM; Arruda VR
    Thromb Haemost; 2000 Feb; 83(2):229-33. PubMed ID: 10739378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTHFR (C677T, A1298C), FV Leiden polymorphisms, and the prothrombin G20210A mutation in arterial ischemic stroke among young tunisian adults.
    M'barek L; Sakka S; Meghdiche F; Turki D; Maalla K; Dammak M; Kallel C; Mhiri C
    Metab Brain Dis; 2021 Mar; 36(3):421-428. PubMed ID: 33400068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Study on Hereditary Thrombophilia and Stroke in a Cohort from Sri Lanka.
    Kalpage HA; Sumathipala DS; Goonasekara HW; Dissanayake VH
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):102-9. PubMed ID: 26522268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes associated with adult cerebral venous thrombosis.
    Marjot T; Yadav S; Hasan N; Bentley P; Sharma P
    Stroke; 2011 Apr; 42(4):913-8. PubMed ID: 21350198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.
    Martinelli I; Battaglioli T; Razzari C; Mannucci PM
    J Thromb Haemost; 2007 Jan; 5(1):98-101. PubMed ID: 17067362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia.
    Lichy C; Reuner KH; Buggle F; Litfin F; Rickmann H; Kunze A; Brandt T; Grau A
    Cerebrovasc Dis; 2003; 16(1):83-7. PubMed ID: 12766367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.
    Martinelli I; Bucciarelli P; Margaglione M; De Stefano V; Castaman G; Mannucci PM
    Br J Haematol; 2000 Dec; 111(4):1223-9. PubMed ID: 11167765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism.
    Bonduel M; Sciuccati G; Hepner M; Pieroni G; Torres AF; Mardaraz C; Frontroth JP
    Am J Hematol; 2003 Jun; 73(2):81-6. PubMed ID: 12749008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
    Ben Salem-Berrabah O; Fekih-Mrissa N; N'siri B; Ben Hamida A; Benammar-Elgaaied A; Gritli N; Mrissa R
    J Clin Neurosci; 2012 Sep; 19(9):1326-7. PubMed ID: 22721898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.